Rivolga Private Limited
About Rivolga Private Limited
Data last updated:
Rivolga Private Limited is a private limited company based in Palakkad, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 January 2022.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24299KL2022PTC073618. Its GSTIN is 32AALCR5919H1Z7 (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6.4 Lakh. It is led by directors including Sreevas S Tholoor and Elampallil Sugunan Suneesh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 33/518(6) Rhine House Aditya Nagar East Vennakkara Nurani P O, Palakkad, Kerala, India – 678004.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.52 Cr, a growth of 113% compared to the previous year. For the same year it recorded a net loss of ₹5.47 Lakh (net margin -2.2%) and EBITDA of ₹29,700 (EBITDA margin 0.1%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rivolga Private Limited's registered office is in Palakkad, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address33/518(6) Rhine House Aditya Nagar East Vennakkara Nurani P O, Palakkad, Kerala, India – 678004
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rivolga Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rivolga is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Rivolga Private Limited, buy the company report.
Financials of Rivolga Private Limited
FY 2025 filings availableRivolga Private Limited reported revenue of ₹2.52 Cr (up 113% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 113% in the latest year. EBITDA rose 101% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹29,700 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹5.47 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.1% | |||
| Net Profit Margin | -2.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Rivolga Private Limited, buy the company report.
Board of directors of Rivolga Private Limited
Rivolga has 7 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sreevas S Tholoor | Director | 25 Jan 2022 | 4 Years 9 Months | Current |
| Elampallil Sugunan Suneesh | Director | 25 Jan 2022 | 4 Years 9 Months | Current |
| Kunjumon Vineesh | Director | 25 Jan 2022 | 4 Years 9 Months | Current |
| Jijo Antony | Director | 25 Feb 2022 | 4 Years 8 Months | Current |
| Nadarsha | Director | 25 Feb 2022 | 4 Years 8 Months | Current |
| Afnaz Ashraf | Director | 25 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Rivolga Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aetherix Lifescience Private Limited | ₹2.55 Cr (FY 2025) | 353.0% | Vadodara, Gujarat, India | |||
| Gemmed Pharmaceuticals Private Limited | ₹2.55 Cr (FY 2025) | 19.0% | Vijayawada, Andhra Pradesh, India | |||
| Makeown Pharma Private Limited | ₹2.55 Cr (FY 2025) | 12.0% | Navi Mumbai, Maharashtra, India | |||
| A S Instruments and Lab Private Limited | ₹2.54 Cr (FY 2025) | -14.0% | Palghar, Maharashtra, India | |||
| Gyaneshwar Multitrade Private Limited | ₹2.53 Cr (FY 2024) | -85.0% | Palghar, Maharashtra, India | |||
| Rivolga Private Limitedthis company | ₹2.52 Cr (FY 2025) | -₹5.47 Lakh | -2.2% | 113.0% | Palakkad, Kerala, India | |
| Expert Equipments Pvt Ltd | ₹2.51 Cr (FY 2025) | -6.0% | Thane, Maharashtra, India | |||
| Vitalis Lifecare Private Limited | ₹2.47 Cr (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Navron Pharma Private Limited | ₹2.45 Cr (FY 2025) | -70.0% | Chennai, Tamil Nadu, India | |||
| Crescenzia Wellness Private Limited | ₹2.45 Cr (FY 2025) | 21.0% | Bangalore, Karnataka, India | |||
| Skin Kinetics Pharmaceuticals Private Limited | ₹2.44 Cr (FY 2025) | 14.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Rivolga Private Limited, buy the company report.
Auditor
Rivolga Private Limited is audited by V VENUGOPALAN AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V VENUGOPALAN AND ASSOCIATES | FY 2023 | 010739S |
Shareholding
The shareholding of Rivolga Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Rivolga Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rivolga Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rivolga Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rivolga Private Limited has 1 active EPFO establishment as of Apr 02, 2024.
GST
Rivolga has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AALCR5919H1Z7 | Kerala | Active | 17 Mar 2022 |
To see the full GST registrations and return filing status of Rivolga Private Limited, buy the company report.
Recent activity
Rivolga Private Limited has 7 board changes on record since 2022: 7 appointments. The latest: Afnaz Ashraf was appointed as Director on 25 Feb 2022.
Frequently asked questions
Rivolga is an active private limited company based in Palakkad, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 January 2022 (4+ years old) and is registered under CIN U24299KL2022PTC073618.
Rivolga has 7 current directors:
- Sreevas S Tholoor - Director
- Elampallil Sugunan Suneesh - Director
- Kunjumon Vineesh - Director
- Jijo Antony - Director
- Nadarsha - Director
- Afnaz Ashraf - Director
- Radha Krishnan Praveen - Director
The latest financial statements of Rivolga on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Rivolga is 32AALCR5919H1Z7, registered in Kerala.
The CIN (Corporate Identification Number) of Rivolga is U24299KL2022PTC073618. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rivolga was incorporated on 25 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Rivolga by revenue are Aetherix Lifescience Private Limited, Gemmed Pharmaceuticals Private Limited, Makeown Pharma Private Limited, A S Instruments and Lab Private Limited, Gyaneshwar Multitrade Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Afnaz Ashraf was appointed as Director on 25 Feb 2022. Jijo Antony was appointed as Director on 25 Feb 2022. Nadarsha was appointed as Director on 25 Feb 2022. Rivolga has 7 board changes on record in total.
The registered office of Rivolga is at 335186 Rhine House Aditya Nagar East Vennakkara Nurani P O, Palakkad, Kerala, India – 678004.
Rivolga operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Rivolga is compliant as of 28 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
